STACI DUNCAN: Open Payments
NPI 1407245285 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 38 payments from 17 companies in 2025. Trend: 2023 $1,016 · 2024 $771 · 2025 $879
Food & beverage: $879
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| Novo Nordisk Inc | 4 | $89 |
| Lilly USA, LLC | 3 | $86 |
| Antares Pharma, Inc. | 4 | $82 |
| Exact Sciences Corporation | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Lundbeck LLC | 2 | $42 |
Products named: LEQVIO, REXULTI, XYOSTED, Ozempic, UBRELVY, JARDIANCE, Cologuard Collection Kit, AIRSUPRA.
Industry payments across WA — which companies pay providers there.
